Preeclampsia and gestational weight gain in the Norwegian Fit for Delivery trial by Hillesund, Elisabet Rudjord et al.
Hillesund et al. BMC Res Notes  (2018) 11:282  
https://doi.org/10.1186/s13104-018-3396-4
RESEARCH NOTE
Preeclampsia and gestational weight gain 
in the Norwegian Fit for Delivery trial
E. R. Hillesund1* , S. Seland1,2, E. Bere1, L. R. Sagedal2,3, M. K. Torstveit1, H. Lohne‑Seiler1, I. Vistad2,3  
and N. C. Øverby1
Abstract 
Objective: Excessive gestational weight gain is linked to risk of preeclampsia, but it is not clear whether the associa‑
tion is causal. The purpose of this paper was to examine gestational weight gain in the Norwegian Fit for Delivery 
study among women who developed preeclampsia compared to those who did not, and to further explore associa‑
tions between weight gain and preeclampsia by including data on body composition (bioimpedance) assessed in the 
last trimester of pregnancy.
Results: A total of 550 women were eligible for the study. Women who developed preeclampsia gained more weight 
than women who did not (difference 3.7 kg, p = 0.004), with a 3.5 kg difference in total body water observed in week 
36 (p = 0.040). Adjusted for age, education, pre‑pregnancy body mass index (BMI), randomization, and fat mass, a one 
kg increase in GWG was associated with 1.3 times higher odds of preeclampsia (OR: 1.31, 95% CI 1.15–1.49, p < 0.001). 
An independent inverse association between fat mass in week 36 and odds of preeclampsia was observed (OR: 0.79, 
95% CI 0.68–0.92, p = 0.002). Given the observed difference in total body water, these findings point to excess fluid as 
the component driving the association between gestational weight gain and preeclampsia in the present study.
Trial registration The NFFD trial has the Clinical Trials registration: clinicaltrial.gov NCT0100168
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Introduction
Preeclampsia is a serious complication of pregnancy with 
an incidence rate of 2–8% worldwide [1]. Preeclampsia is 
defined as the development of hypertension and protein-
uria after 20 weeks of gestation [2] and is a leading cause 
of maternal mortality and morbidity, perinatal deaths, 
and preterm delivery [3]. Preeclampsia is also associated 
with intrauterine growth restriction with immediate and 
long-term risks for the child [4]. The causes of preec-
lampsia are not well established. A leading hypothesis 
is placental dysfunction from early pregnancy [5] that 
leads to placental ischemia and an exaggerated maternal 
systemic inflammatory reaction to pregnancy. Maternal 
gestational weight gain (GWG) has received attention 
as a potentially modifiable risk factor for preeclampsia, 
however the results are inconclusive, with some stud-
ies suggesting an association [6–9] and others not [10, 
11]. The fact that gestational weight gain (GWG) is a 
composite of fat mass, fat-free mass, and extracellu-
lar fluid accrual complicates the interpretation of these 
observations.
The aim of this paper is to examine gestational weight 
gain (GWG) of women in the Norwegian Fit for Deliv-
ery trial (NFFD) who developed preeclampsia compared 
to those who did not, and to further explore associations 
between GWG and preeclampsia by including body com-
position data measured in the last trimester of pregnancy.
Main text
Methods
Data were derived from the Norwegian Fit for Delivery 
study, a randomized controlled trial where 606 nullipa-
rous women were included and randomized to a life-
style intervention group (physical activity sessions and 
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dietary guidance) or a control group (clinicaltrial.gov 
NCT0100168) [12]. Participants were recruited by mid-
wives at eight health care clinics in the Southern part of 
Norway between September 2009 and February 2013. 
Inclusion criteria were primiparity, age above 18  years, 
body mass index (BMI) above 19, and being literate in 
either Norwegian or English. Exclusion criteria were twin 
gestation, pre-existing diabetes, and inability to partici-
pate in the physical activity part of the program. Partici-
pants had to be recruited into the study before pregnancy 
week 20.
The current paper used data from all participants 
regardless of randomization assignment. In total 550 
women of the 606 participants originally randomized 
were included in the present analysis.
Subjects
Of the 606 women, 32 were excluded due to not meeting 
inclusion criteria (19 with BMI < 19 kg/m2, five recruited 
too late in pregnancy, 3 abortions, 3 moving away, one 
not nulliparous, and one pregnant with twins). In total 
19 participants withdrew their consent to participate 
after inclusion and randomization. A total of 13 of these 
did not give a reason, while 4 said they did not want to 
participate in the sports activity, one did not want to be 
in the control group, and one did not want to take blood 
tests. In addition, five more were excluded because of 
missing information on preeclampsia.
Instruments
Pre-pregnancy weight was based on self-reported values 
given in kilograms (kg). Participants were also weighed 
at the health care clinic at study inclusion on scales that 
were calibrated at study start. Every participant had two 
separate examinations at Sørlandet hospital (gestational 
week 30 and 36) where weight was measured with a bio-
impedance scale (Tanita BC 418, Tokyo, Japan) with 
0.1 kg precision. The scale measures fat percentage, total 
fat mass, total fat-free mass and total body water. The 
women were measured with light clothing and no shoes. 
Weight at delivery was measured by a SECA weight with 
0.1 kg precision. If weight at delivery was not recorded, 
the last weight measured at the health care clinic were 
used. Height was measured with a portable stadiometer 
(Seca Leicester, Hamburg, Germany) at the consultation 
in week 30. Pre-pregnancy BMI in kg/m2 was calculated 
using self-reported weight and height measured in week 
30. Weight gain in pregnancy was calculated both from 
self-reported pre-pregnancy weight and from weight 
measured at study inclusion. Total pregnancy weight gain 
was only calculated for women who gave birth after week 
37. Weekly weight gain in each trimester was computed 
for all participants. Excessive GWG was defined as > 16, 
> 11.5 and > 9 kg if normal weight, overweight and obese 
pre-pregnancy, respectively, according to Institute of 
Medicine (IOM) recommendations [13].
Participants responded to a questionnaire at inclusion 
and in week 36. Descriptive information on age at inclu-
sion, smoking, randomization assignment, and education 
were collected from the baseline questionnaire. Educa-
tional attainment was categorized as ≤ 12, 13–15, and 
≥ 16 years.
Preeclampsia was diagnosed based on guidelines 
adopted by the Norwegian Federation of Obstetricians 
and Gynecologists; an increase in blood pressure to at 
least ≥ 140 mm Hg systolic or 90 mm Hg diastolic after 
20th gestational week combined with proteinuria (pro-
tein excretion of at least 0.3 g/24 h or ≥ 1+ on dip-stick), 
both measured at least twice [14]. Severe preeclampsia 
was defined as preeclampsia before 34  weeks of preg-
nancy and/or severity of symptoms, as documented in 
hospital charts, including cases of eclampsia and HELLP 
(hemolysis, elevated liver enzymes, low platelet count). 
All cases were ascertained retrospectively from hospital 
charts.
Statistical analysis
Independent sample t-tests were performed for normally 
distributed data, mainly those related to weight develop-
ment. Values are given in mean and standard deviation 
(SD). Mann–Whitney U-test was used to compare non-
normally distributed data and are presented as median 
and interquartile range (Q1–Q3). Chi square tests were 
performed for comparison of categorical data. We 
assessed associations between total GWG (continuous 
in kg) and excessive GWG (yes/no) and preeclampsia in 
crude and multivariate binary logistic models that were 
adjusted for maternal age, education, randomization 
assignment, pre-pregnant BMI, and fat mass in week 30 
or 36, respectively. Associations are presented as odds 
ratios (OR) with 95% confidence intervals (CI). A p-value 
of < 0.05 was considered significant.
Results
Of the 550 women included, 25 (4.5%) developed preec-
lampsia, with a non-significant difference of 3.6% in 
the intervention group and 5.4% in the control group. 
Among the 25 preeclampsia cases, 15 (60%) were classi-
fied as severe.
There was no difference in maternal age, gestational 
age at inclusion, educational attainment, smoking hab-
its, or diabetes prevalence between those with and 
without preeclampsia (Table  1). Those who developed 
preeclampsia had significantly shorter pregnancy dura-
tion than those who did not (p < 0.001), and more often 
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instrumental delivery (p < 0.001) because of induced 
delivery and planned cesarean section.
There were no significant differences regarding mater-
nal pre-pregnancy weight, maternal or paternal pre-preg-
nancy BMI, maternal fat mass, or % body fat between 
those who developed preeclampsia and those who did 
not, but participants who developed preeclampsia had 
higher total body water in week 36 (difference 3.5  kg, 
p = 0.040) (Table 2).
Participants who developed preeclampsia had higher 
total GWG (difference 3.7  kg, p = 0.004) and higher 
weekly weight gain as calculated from pre-pregnancy to 
study inclusion (difference 88  g/week, p = 0.031), from 
inclusion to week 30 (difference 131  g/week, p = 0.005), 
and from week 30 to 36 (difference 210 g/week, p = 0.004) 
(Table 2).
Adjusted for maternal age, education, pre-pregnancy 
BMI, randomization, and fat mass in week 30, a 1  kg 
increase in total GWG increased the odds of preeclamp-
sia (OR: 1.21, 95% CI 1.09–1.34, p < 0.001). The associa-
tion was similar when fat mass in week 30 was replaced 
by fat mass in week 36 in the model (OR: 1.31, 95% CI 
1.15–1.49, p < 0.001). An independent inverse relationship 
between fat mass and odds of preeclampsia was observed 
in both models (OR: 0.85, 95% CI 0.74–0.98, p = 0.021 
for fat mass measured in week 30, and OR: 0.79, 95% CI 
0.68–0.92, p = 0.002 for fat mass measured in week 36). 
An independent association between pre-pregnancy BMI 
and preeclampsia was also observed (OR: 1.43, 95% CI 
1.08–1.90, p = 0.012) adjusted for fat mass in week 30, 
and OR: 1.71, 95% CI 1.26–2.31, p = 0.001 adjusted for fat 
mass in week 36).
We reran the adjusted models with excessive GWG as 
the main exposure. Excessive GWG was associated with 
higher odds of preeclampsia (OR: 3.54, 95% CI 1.15–
10.91, p = 0.028 adjusted for fat mass in week 30, and 
OR: 5.43, 95% CI 1.34–21.98, p = 0.018 adjusted for fat 
mass in week 36). Neither fat mass nor any other covari-
ates were independently associated with preeclampsia in 
these models.
To assess potential influence of the lifestyle interven-
tion we reran the adjusted models confined to the con-
trol group. All associations remained significant in the 
restricted sample (data not shown).
Discussion
Women in the NFFD study who developed preeclampsia 
gained significantly more weight throughout pregnancy 
than women who did not, and 3 in 4 with preeclampsia 
had excessive GWG according to IOM recommenda-
tions. A significant association between GWG and preec-
lampsia remained after adjustment for age, education, 
pre-pregnancy BMI, randomization, and 3rd trimester 
fat mass. The association was not driven by increased fat 
mass as evidenced by the fact that fat mass was inversely 
associated with preeclampsia risk.
The difference in gestational weight gain among 
women with and without preeclampsia was evident early, 
with significant higher weight gain throughout preg-
nancy in women who developed preeclampsia. There was 
no difference between the groups in fat mass in week 30 
and 36, but an increasing difference in total body water 
during the same time window, suggesting edemas at that 
point in preeclamptic pregnancies. The difference in total 
Table 1 Description of  participants, including  the  whole sample, participants with  no  preeclampsia and  participants 
with preeclampsia
a For normally distributed data, Independent-samples t-test was used with values presented as mean (SD). b For non-normally distributed data, Mann–Whitney U-test 
was used and values given as median (Q1–Q3). c For categorical variables, Chi square test was performed, and values given in percent
Whole sample 
(n = 550)
No preeclampsia 
(n = 525)
Preeclampsia (n = 25) p-valuea,b,c
Age, years 28.0 (4.4) 28.0 (4.3) 29.4 (4.6) 0.116
Gestational age at inclusion 108 (17) 108 (17) 106 (20) 0.607
Belonging to intervention group, % 49.8 50.3 40.0 0.424
Smoking, % 3.8 3.8 4.0 1.0
Gestational diabetes, diet‑regulated, % 8.4 8.4 8.0 0.862
Gestational diabetes, insulin, % 1.1 1.1 0.0
Pregnancy duration, weeks 40 (39–41) 40 (39–41) 38 (36–39) < 0.001
% instrumental delivery 21.5 19.8 60.9 < 0.001
Education
 3‑year high school or less 30.8 30.8 32.0 0.523
 University/university college less than 4 years 33.8 34.2 24.0
 University/university college more than 4 years 35.4 35.0 44.0
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gestational weight gain almost equaled the difference in 
total body water in week 36.
Our findings regarding associations between GWG and 
preeclampsia are in line with several other studies [6, 7, 
9], although there is still conflicting evidence [10, 11]. 
Underlying mechanisms for a potential causal associa-
tion between weight gain per se and preeclampsia could 
be that excessive GWG may increase oxidative stress, 
and thereby stimulate or aggravate a systemic inflamma-
tory response which could accelerate damage to vascular 
endothelial cells leading to preeclampsia [15]. Magnus 
et  al. argue that reverse causation must be considered 
as an explanation of the association between GWG 
and preeclampsia because edemas will cause increased 
weight gain [16]. Our findings by including body compo-
sition measurements in the models support this view.
To date, lifestyle interventions targeting GWG through 
diet and physical activity have not been convincingly 
successful in reducing the prevalence of preeclampsia, 
even with successful reductions in GWG [17]. If exces-
sive GWG is a consequence of preeclampsia rather than 
a causal factor in the etiology of preeclampsia it may be 
prudent to focus more on diet quality and other health 
behaviors that may modify the stress response to preg-
nancy rather than on modifying weight gain per se.
Weight gain was larger in all three trimesters in preec-
lamptic pregnancies, even in early pregnancy when ede-
mas are not likely to be present. To our knowledge this 
has not been reported previously. This raises the ques-
tion whether early rapid (or excessive) weight gain could 
be indicative of underlying pathophysiological processes 
and should lead to closer attention and intensified follow-
up. Tiralongo et al. found differences in maternal hemo-
dynamics in the first trimester of pregnancy that could 
influence risk preeclampsia [18]. Of note, pre-pregnancy 
weight was self-reported, so the comparison of weight 
gain before inclusion is less reliable and should not be 
given too much weight.
In conclusion, the present study supports the previ-
ously described association between gestational weight 
gain and preeclampsia. The association was, however, 
not driven by increased fat mass. We therefore ques-
tion whether excessive GWG is a causal factor in the 
pathophysiology of preeclampsia, or rather an indica-
tion of early endothelial dysfunction leading to excess 
fluid retention from an early stage of pregnancy. Early 
Table 2 Comparison of weight and weight development between women without and with preeclampsia
Weight gain in pregnancy (based on pre-pregnancy weight): missing = 21. Weight gain in pregnancy (based on weight at study inclusion): missing = 26. Weight gain 
per week from pre-pregnancy to inclusion: missing = 18
Weight gain per week from inclusion to week 30: missing = 35. Weight gain from week 30 to 36: missing = 45. Fat percentage and fat mass in week 30: missing = 51. 
Total Body Water in week 30: missing = 49. Total Body Water in week 36: Missing = 58
Excessive GWG according to Institute of Medicine 2009 [13], a total of 536 women
a Independent-samples t-test. b Chi square test. * Significance level p < 0.05
Total 
sample 
(n = 550)
No pre-
eclampsia 
(n = 525)
Preeclampsia (n = 25) Difference p-valuea,b
Pre‑pregnancy weight (kg)a 68.0 (12.1) 68.0 (12.0) 67.5 (14.6) 0.5 0.840
Pre‑pregnancy BMI (kg/m2)a 23.8 (3.8) 23.8 (3.8) 24.2 (4.0) − 0.3 0.657
Normal‑weight, %b 71.6 71.2 80.0 0.604
Overweight, %b 21.5 20.8 16.0
Obese, %b 7.8 8.0 4.0
Paternal BMI, (kg/m2)a 25.5 (3.2) 25.6 (3.2) 24.9 (3.5) 0.6 0.377
Weight gain in pregnancy,  kga (from pre‑pregnancy weight) 15.1 (6.1) 14.9 (6.0) 18.6 (7.1) − 3.7 0.004
Weight gain in pregnancy, kg (from weight at inclusion)a 12.7 (5.0) 12.6 (4.9) 14.8 (6.0) − 2.2 0.040*
Weight gain per week from pre‑pregnancy to inclusion,  gramsa 152 (196) 148 (194) 236 (217) − 88 0.031*
Weight gain per week from inclusion to week 30,  gramsa 504 (214) 498 (210) 629 (279) − 131 0.005*
Weight gain per week from week 30–36,  gramsa 554 (298) 547 (293) 757 (361) − 210 0.004*
Fat percentage, week 30, %a 35.4 (5.2) 35.4 (5.2) 35.0 (5.8) 0.4 0.732
Fat mass, week 30,  kga 28.0 (8.5) 28.0 (8.4) 29.2 (11.6) − 1.2 0.523
Fat percentage. week 36, %a 35.5 (5.2) 35.5 (5.2) 34.6 (6.8) 1.0 0.483
Fat mass, week 36,  kga 29.3 (8.8) 29.2 (8.6) 31.6 (14.6) − 2.4 0.537
Total body water, week 30,  kga 36.4 (3.6) 36.3 (3.5) 38.0 (5.7) − 1.7 0.188
Total body water, week 36, %a 37.7 (3.9) 37.8 (3.8) 41.2 (5.9) − 3.5 0.040*
Excessive GWG (%)b 51.7 47.2 73.9 − 26.7 0.012*
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weight gain combined with measurement of body com-
position in early pregnancy should be further explored 
in relation to subsequent development of preeclampsia.
Limitations
Strengths to this study are the weight and height meas-
urements performed with calibrated scales at sev-
eral time points throughout pregnancy, and the body 
composition measurements performed in gestational 
weeks 30 and 36 of pregnancy. Pre-pregnancy weight 
was self-reported, thus differences in weight gain in 
early pregnancy is less reliable than in later pregnancy. 
Løf et  al. assessed body composition at several time-
points throughout pregnancy and concluded that bio-
impedance spectroscopy is potentially useful although 
increases in TBW during pregnancy tends to be under-
estimated [19].
The limited number of preeclampsia cases and the 
numerical difference between cases and non-cases 
might compromise confidence in the magnitude of the 
effect estimates in the present analyses. The small sam-
ple of cases, and the fact that standard deviations were 
larger for all body weight-related variables in the preec-
lampsia group, would tend to reduce the likelihood of 
identifying true differences between the groups.
Residual and unmeasured confounding may remain, 
but we repeated all analyses confined to the control 
group alone to address potential residual confounding 
due to the lifestyle intervention. Due to similar find-
ings, we chose to present the results from the total 
sample with adjustment for randomization assignment. 
Generalizations should, however, be done with caution 
as women were recruited from a limited geographical 
area in Norway and represents a relatively highly edu-
cated population.
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